Influence of Cytarabine Metabolic Pathway Polymorphisms in Acute Myeloid Leukemia Induction Treatment

被引:0
作者
Megias-Vericat, Juan Eduardo [1 ,2 ]
Pau, Montesinos [3 ]
Herrero, Maria Jose [2 ,4 ]
Moscardo, Federico [3 ]
Boso, Virginia [2 ,4 ]
Martinez-Cuadron, David [3 ]
Rojas, Luis [2 ,4 ]
Rodriguez-Veiga, Rebeca [3 ]
Hervas, David [5 ]
Boluda, Blanca [3 ]
Sendra, Luis [4 ]
Sanz, Jaime [6 ]
Miguel, Antonio [4 ]
Cervera, Jose [7 ]
Poveda, Jose Luis [1 ,2 ]
Alino, Salvador F. [8 ,9 ,10 ]
Sanz, Miguel Angel [3 ]
机构
[1] Hosp Univ Politecn Fe, Dept Pharm, Drug Clin Area, Valencia, Spain
[2] Inst Invest Sanitaria Fe, Valencia, Spain
[3] Hosp Univ Politecn Fe, Dept Hematol, Valencia, Spain
[4] Hosp Univ Politecn Fe, Pharmacogenet Unit, Drug Clin Area, Valencia, Spain
[5] Inst Invest Sanitaria Fe, Biostatist Unit, Valencia, Spain
[6] Hosp Univ Politecn Fe, Valencia, Spain
[7] Hosp Univ Politecn Fe, Genet Unit, Hematol Serv, Valencia, Spain
[8] Univ Valencia, Pharmacogenet Unit, Drug Clin Area, Valencia, Spain
[9] Univ Valencia, Clin Pharmacol Unit, Hosp Univ Politec Fe, Valencia, Spain
[10] Univ Valencia, Fac Med, Dept Pharmacol, Valencia, Spain
关键词
D O I
10.1182/blood.V128.22.5130.5130
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
5130
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Venetoclax plus cyclophosphamide and cytarabine as induction regimen for adult acute myeloid leukemia
    Zhang, Baohang
    Liu, Qingguo
    Li, Junfan
    Hu, Yimin
    Zhao, Xin
    Huang, Pingping
    Li, Shangzhu
    Wang, Ying
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [22] A randomized study of high-dose cytarabine in induction in acute myeloid leukemia
    Bishop, JF
    Matthews, JP
    Young, GA
    Szer, J
    Gillett, A
    Joshua, D
    Bradstock, K
    Enno, A
    Wolf, MM
    Fox, R
    Cobcroft, R
    Herrmann, R
    VanDerWeyden, M
    Lowenthal, RM
    Page, F
    Garson, OM
    Juneja, S
    BLOOD, 1996, 87 (05) : 1710 - 1717
  • [23] Acute Pancreatitis Associated With Cytarabine During the Treatment of Pediatric Acute Myeloid Leukemia
    Murshed, Farhan
    Wong, Victor
    Koning, Jeffrey L.
    Kuo, Dennis J.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2020, 42 (01) : 63 - 64
  • [24] Pathway Based Evaluation of Cytarabine Pharmacogenetics in Children with Acute Myeloid Leukemia.
    Myers, Kasian C.
    Gerbing, Robert B.
    Alonzo, Todd A.
    Phillips, Christine L.
    Gamis, Alan S.
    Radloff, Gretchen A.
    Perentesis, John
    Davies, Stella M.
    BLOOD, 2009, 114 (22) : 1024 - 1024
  • [25] Population pharmacokinetics of cytarabine, etoposide, and daunorubicin in the treatment for acute myeloid leukemia
    Krogh-Madsen, Mikkel
    Bender, Brendan
    Jensen, Morten Krogh
    Nielsen, Ove Juul
    Friberg, Lena E.
    Honore, Per Hartvig
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (05) : 1155 - 1163
  • [26] LOW-DOSE CYTARABINE IN THE TREATMENT OF ACUTE MYELOID-LEUKEMIA
    BERIS, P
    RIEDER, A
    ANDREY, C
    HELG, C
    CHAPUIS, B
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1984, 114 (48) : 1763 - 1766
  • [27] Population pharmacokinetics of cytarabine, etoposide, and daunorubicin in the treatment for acute myeloid leukemia
    Mikkel Krogh-Madsen
    Brendan Bender
    Morten Krogh Jensen
    Ove Juul Nielsen
    Lena E. Friberg
    Per Hartvig Honoré
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 1155 - 1163
  • [28] The association of topotecan and cytarabine in the treatment of secondary or relapsed acute myeloid leukemia
    Pagano, L
    Mele, L
    Voso, MT
    Chiusolo, P
    Putzulu, R
    Mazzotta, S
    Leone, G
    HAEMATOLOGICA, 2001, 86 (04) : 440 - 441
  • [29] COMBINATION OF CLOFARABINE AND CYTARABINE IN THE TREATMENT OF REFRACTORY OR RELAPSED ACUTE MYELOID LEUKEMIA
    Spassov, B.
    Balatzenko, G.
    Angelova, S.
    Toshkov, S.
    Guenova, M.
    Arnaudov, G.
    Mihaylov, G.
    HAEMATOLOGICA, 2015, 100 : 377 - 377
  • [30] RAPID RESPIRATORY DECLINE FOLLOWING CYTARABINE TREATMENT IN ACUTE MYELOID LEUKEMIA
    Rosa, Sherley
    Olivera, Samille
    Rivas, Pedro
    Ortiz, Ivanisse
    Olan, Jonathan Torrens
    Quintana, Hiram Maldonado
    CRITICAL CARE MEDICINE, 2025, 53 (01)